Stocks
UCB S.A.UCBJY
OTCHealthcareBiotechnology$143.36-1.17%
A Belgian biopharmaceutical company focused on developing treatments for neurological and immunological disorders, with key products addressing epilepsy, psoriasis, and inflammatory diseases. Its portfolio includes drugs such as Cimzia and Bimzelx, alongside a pipeline targeting central nervous syst...
Market Cap: $54.6B52W Range: $71.16 – $168.76
Congressional Interest in UCB S.A. (UCBJY)
2 members of Congress have disclosed 3 trades in UCB S.A. (UCBJY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
2
Buys
1
Sells
2
Who in Congress Is Trading UCBJY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-09-23 | Valerie Hoyle | sell | $1K – $15K |
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |